PLOS Medicine: Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
![High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial - The Lancet Infectious Diseases High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2106141822/2081480216/gr1.gif)
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial - The Lancet Infectious Diseases
![A Collaborative Approach for “ReSeq-ing” Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers - eBioMedicine A Collaborative Approach for “ReSeq-ing” Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2098606013/2078800974/gr1.jpg)
A Collaborative Approach for “ReSeq-ing” Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers - eBioMedicine
![Building Capacity for Tuberculosis Research in China: The China TB Clinical Trials Consortium (CTCTC) - FHI Clinical Building Capacity for Tuberculosis Research in China: The China TB Clinical Trials Consortium (CTCTC) - FHI Clinical](https://www.fhiclinical.com/wp-content/uploads/2019/08/TB_casestudy_CallOut_01-493x1024.png)
Building Capacity for Tuberculosis Research in China: The China TB Clinical Trials Consortium (CTCTC) - FHI Clinical
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials | PLOS Medicine
![Applying a risk-benefit analysis to outcomes in tuberculosis clinical trials | Center For Clinical Global Health Education Applying a risk-benefit analysis to outcomes in tuberculosis clinical trials | Center For Clinical Global Health Education](https://main.ccghe.net/sites/default/files/pictures/2020-02-03-Clinical-Trial-Word-Art-shutterstock_69750982-LEFT-GRID.jpg)
Applying a risk-benefit analysis to outcomes in tuberculosis clinical trials | Center For Clinical Global Health Education
![NIH launches large TB prevention trial for people exposed to multidrug-resistant TB | National Institutes of Health (NIH) NIH launches large TB prevention trial for people exposed to multidrug-resistant TB | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2018/20180309-tb.jpg?itok=U03HxCfZ×tamp=1520612556)
NIH launches large TB prevention trial for people exposed to multidrug-resistant TB | National Institutes of Health (NIH)
![Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future - International Journal of Infectious Diseases Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9b90136-0522-4db4-9c45-ff65ef4b9130/gr1_lrg.jpg)